However, GSI treatment significantly reduced AhR mRNA expression in CD4+ T cells purified from tumor site (P<0.0001, Figure 3G), while slightly decreased AhR expression in CD4+ T cells purified from nontumor site (P=0.006, Figure 3G). The gene discussed is CD4; the disease is neoplasm.